Evidence map›Paper›PMID 25655563›Full record

ArticleScientific reports2015

System-wide analysis of the transcriptional network of human myelomonocytic leukemia cells predicts attractor structure and phorbol-ester-induced differentiation and dedifferentiation transitions.

Katsumi Sakata, Hajime Ohyanagi, Shinji Sato, Hiroya Nobori, Akiko Hayashi, Hideshi Ishii, Carsten O Daub, Jun Kawai, Harukazu Suzuki, Toshiyuki Saito

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Katsumi Sakata1] National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba-city, Chiba 263-8555, Japan [2] Maebashi Institute of Technology, 460-1 Kamisadori-machi, Maebashi-city, Gunma 371-0816, Japan.
Hajime Ohyanagi1] National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba-city, Chiba 263-8555, Japan [2] Maebashi Institute of Technology, 460-1 Kamisadori-machi, Maebashi-city, Gunma 371-0816, Japan [3] Mitsubishi Space Software Co., Ltd., Tsukuba-Mitsui Building, 1-6-1 Takezono, Tsukuba-city, Ibaraki 305-0032, Japan [4] National Institute of Genetics, 1111 Yata, Mishima-city, Shizuoka 411-8540, Japan.
Shinji SatoMaze Inc., 1-2-17 M604, Sennin-machi, Hachioji-city, Tokyo 193-0835, Japan.
Hiroya NoboriMitsubishi Space Software Co., Ltd., Tsukuba-Mitsui Building, 1-6-1 Takezono, Tsukuba-city, Ibaraki 305-0032, Japan.
Akiko HayashiNational Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba-city, Chiba 263-8555, Japan.
Hideshi Ishii1] National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba-city, Chiba 263-8555, Japan [2] Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita-city, Osaka 565-0871, Japan.
Carsten O Daub1] RIKEN Omics Science Center, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama-city, Kanagawa, 230-0045, Japan [2] RIKEN Center for Life Science Technologies, Division of Genomic Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama-city, Kanagawa, 230-0045, Japan [3] Department of Biosciences and Nutrition and Science for Life Laboratory, Karolinska Institutet, Stockholm, SE-141 86, Sweden.
Jun Kawai1] RIKEN Omics Science Center, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama-city, Kanagawa, 230-0045, Japan [2] RIKEN Preventive Medicine and Diagnosis Innovative Program, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
Harukazu Suzuki1] RIKEN Omics Science Center, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama-city, Kanagawa, 230-0045, Japan [2] RIKEN Center for Life Science Technologies, Division of Genomic Technologies, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama-city, Kanagawa, 230-0045, Japan.
Toshiyuki SaitoNational Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba-city, Chiba 263-8555, Japan.
CE Technologies (United Kingdom) · GBInstitute of Applied Biochemistry · JPMaebashi Institute of Technology · JPMitsubishi Space Software (Japan) · JPNational Institute of Technology, Tokyo College · JPOsaka City University · JPRIKEN Center for Sustainable Resource Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a system-wide transcriptional network structure that controls cell types in the context of expression pattern transitions that correspond to cell type transitions. Co-expression based analyses uncovered a system-wide, ladder-like transcription factor cluster structure composed of nearly 1,600 transcription factors in a human transcriptional network. Computer simulations based on a transcriptional regulatory model deduced from the system-wide, ladder-like transcription factor cluster structure reproduced expression pattern transitions when human THP-1 myelomonocytic leukaemia cells cease proliferation and differentiate under phorbol myristate acetate stimulation. The behaviour of MYC, a reprogramming Yamanaka factor that was suggested to be essential for induced pluripotent stem cells during dedifferentiation, could be interpreted based on the transcriptional regulation predicted by the system-wide, ladder-like transcription factor cluster structure. This study introduces a novel system-wide structure to transcriptional networks that provides new insights into network topology.

Indexed as

Gene Expression Regulation, LeukemicGene Regulatory NetworksModels, BiologicalTranscription, GeneticCell DifferentiationCell Line, TumorCluster AnalysisComputational BiologyHumansLeukemia, Myelomonocytic, AcutePhorbol EstersPhorbol Esters

Identifiers

PMID25655563
PMCPMC4319166
OpenAlexW2064817133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.